WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark CTX001 was filed as Word mark on 10/09/2018 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1471636 |
| Countries | 
|
| Base trademark |
No. 87872108,
April 11, 2018
|
| Application date | October 9, 2018 |
| Expiration date | February 18, 2022 |
Trademark owner
50 Northern Avenue
Boston MA 02210
US
Boston MA 02210
US
Trademark representatives
Womble Bond Dickinson (US) LLP,
470 Atlantic Avenue, Suite 600
US
goods and services
05
Cells for medical or clinical use; pharmaceutical and
biopharmaceutical agents for the treatment of sickle cell
disease and b-thalassemi; pharmaceutical products and
preparations, namely, gene transfer, regulation, modulation
and delivery pharmaceuticals for the treatment of genetic
diseases and disorders
10
Gene therapy apparatus and instruments, namely, surgical,
medical apparatus and instruments for gene transfer,
regulation, modulation and delivery pharmaceuticals for the
treatment of genetic diseases and disorders; surgical,
medical apparatus and instruments for gene editing
42
Gene editing (terms considered too vague by the
International Bureau – Rule 13 (2) (b) of the Common
Regulations)
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 23, 2023 | 2023/7 Gaz | US | RAW: Total Ceasing Effect |
| October 29, 2020 | 2020/47 Gaz | CH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 20, 2020 | 2020/18 Gaz | CH | Rejection |
| November 15, 2019 | 2019/47 Gaz | EM | Rejection |
| August 28, 2019 | 2019/35 Gaz | GB | Rejection |
| October 9, 2018 | 2019/22 Gaz | US | Registration |
ID: 141471636